Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001941087 | SCV002216984 | likely benign | Nemaline myopathy 6 | 2022-06-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003167356 | SCV003888482 | uncertain significance | Inborn genetic diseases | 2023-02-09 | criteria provided, single submitter | clinical testing | The c.937C>T (p.R313W) alteration is located in exon 1 (coding exon 1) of the KBTBD13 gene. This alteration results from a C to T substitution at nucleotide position 937, causing the arginine (R) at amino acid position 313 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |